Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human GFAP ELISA Kit (AC3144)
Cat.#: ASET-1733
Specifications
Description Human GFAP ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human GFAP concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.026 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.5-8 ng/mL Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1767 Human Neurokinin B Receptor ELISA Kit (AC3178) Quantitative inquiry ASET-1510 Rat Semaphorin 7a ELISA Kit (AC2921) Quantitative inquiry ASET-1709 Canine alpha Synuclein ELISA Kit (AC3120) Quantitative inquiry ASET-1205 Rat PON2 ELISA Kit (AC2616) Quantitative inquiry ASET-1009 Rat Apelin ELISA Kit (AC2420) Quantitative inquiry ASET-2265 Mouse Hes1 ELISA Kit (AC3676) Quantitative inquiry ASET-2262 Mouse Sema3f ELISA Kit (AC3673) Quantitative inquiry ASET-2232 Rat GCLM ELISA Kit (AC3643) Quantitative inquiry ASET-1353 Human Eph Receptor A3 ELISA Kit (AC2764) Quantitative inquiry ASET-1141 Human Dio3 ELISA Kit (AC2552) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket